Yahoo
    OTC Markets OTCPK - Delayed Quote USD

    Novartis AG (NVSEF)

    150.12 0.00 (0.00%)
    At close: October 27 at 4:00:00 PM EDT
    NVSEF Q3 2026 earnings call
    Replay the call for the latest insights.
    Loading Chart for NVSEF
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Gecina: 16 Capucines Leased to the Global Leader in Tech and Data Infrastructure Security

    Gecina: 16 Capucines Leased to the Global Leader in Tech and Data Infrastructure Security
    Business Wire 5h ago
    AB Artea Bank Group’s Operating Results for the First Nine Months of 2026

    AB Artea Bank Group’s Operating Results for the First Nine Months of 2026
    GlobeNewswire 10h ago
    How Are LLY's Neuroscience and Immunology Drugs Poised Ahead of Q3?

    How Are LLY's Neuroscience and Immunology Drugs Poised Ahead of Q3?
    Zacks 12h ago
    Lilly shuffles business structure; Novartis writes off part of Avidity deal

    Lilly shuffles business structure; Novartis writes off part of Avidity deal
    BioPharma Dive 12h ago
    UBS cuts Ems-Chemie to Neutral on premium valuation; shares slide

    UBS cuts Ems-Chemie to Neutral on premium valuation; shares slide
    Investing.com 13h ago
    Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

    Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
    GlobeNewswire 14h ago
    Novartis (SWX:NOVN) Stock Faces Q3 Earnings Squeeze After Profit Slump

    Novartis (SWX:NOVN) Stock Faces Q3 Earnings Squeeze After Profit Slump
    Simply Wall St. 15h ago
    Siam Cement Shares Rose Even As Profit Fell

    Siam Cement Shares Rose Even As Profit Fell
    Simply Wall St. 17h ago
    Norwegian Air Q3 operating profit beats forecasts on strong summer demand

    Norwegian Air Q3 operating profit beats forecasts on strong summer demand
    Investing.com 17h ago
    The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie

    The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
    Zacks 18h ago
    Melexis posts in-line Q3 results, maintains H2 guidance

    Melexis posts in-line Q3 results, maintains H2 guidance
    Investing.com 18h ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: